SG11202001925WA - Substituted imidazoquinolines - Google Patents

Substituted imidazoquinolines

Info

Publication number
SG11202001925WA
SG11202001925WA SG11202001925WA SG11202001925WA SG11202001925WA SG 11202001925W A SG11202001925W A SG 11202001925WA SG 11202001925W A SG11202001925W A SG 11202001925WA SG 11202001925W A SG11202001925W A SG 11202001925WA SG 11202001925W A SG11202001925W A SG 11202001925WA
Authority
SG
Singapore
Prior art keywords
substituted imidazoquinolines
imidazoquinolines
substituted
Prior art date
Application number
SG11202001925WA
Other languages
English (en)
Inventor
Christophe Henry
Original Assignee
BioNTech SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BioNTech SE filed Critical BioNTech SE
Publication of SG11202001925WA publication Critical patent/SG11202001925WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4738Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
SG11202001925WA 2017-09-06 2018-08-31 Substituted imidazoquinolines SG11202001925WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2017/072352 WO2019048036A1 (en) 2017-09-06 2017-09-06 SUBSTITUTED IMIDAZOQUINOLINES
PCT/EP2018/073470 WO2019048350A1 (en) 2017-09-06 2018-08-31 SUBSTITUTED IMIDAZOQUINOLINES

Publications (1)

Publication Number Publication Date
SG11202001925WA true SG11202001925WA (en) 2020-04-29

Family

ID=59914433

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202001925WA SG11202001925WA (en) 2017-09-06 2018-08-31 Substituted imidazoquinolines

Country Status (14)

Country Link
US (2) US11267813B2 (ru)
EP (1) EP3679038B1 (ru)
JP (1) JP7241738B2 (ru)
KR (1) KR20200050963A (ru)
CN (1) CN111094287A (ru)
AU (1) AU2018327414B2 (ru)
BR (1) BR112020004504A2 (ru)
CA (1) CA3074166A1 (ru)
IL (1) IL273002B2 (ru)
MX (1) MX2020002367A (ru)
RU (1) RU2768629C2 (ru)
SG (1) SG11202001925WA (ru)
WO (2) WO2019048036A1 (ru)
ZA (2) ZA202001266B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019048036A1 (en) * 2017-09-06 2019-03-14 Biontech Ag SUBSTITUTED IMIDAZOQUINOLINES
PT3679025T (pt) * 2017-09-06 2022-06-01 BioNTech SE Imidazoquinolinas substituídas como agonistas de tlr7
CU24679B1 (es) * 2019-03-07 2023-09-07 BioNTech SE Proceso para la preparación de una imidazoquinolina sustituida
BR112022008039A2 (pt) * 2019-10-29 2022-07-12 Prime Reach Trading Ltd Compostos de 4-amino-imidazoquinolina e usos relacionados
WO2023083439A1 (en) * 2021-11-09 2023-05-19 BioNTech SE Tlr7 agonist and combinations for cancer treatment

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS585623B2 (ja) 1976-07-12 1983-02-01 日本電信電話株式会社 ファクシミリ通信方式
US6451810B1 (en) 1999-06-10 2002-09-17 3M Innovative Properties Company Amide substituted imidazoquinolines
US6756382B2 (en) 1999-06-10 2004-06-29 3M Innovative Properties Company Amide substituted imidazoquinolines
US6573273B1 (en) 1999-06-10 2003-06-03 3M Innovative Properties Company Urea substituted imidazoquinolines
US6677349B1 (en) 2001-12-21 2004-01-13 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
AU2003223467B2 (en) 2002-04-08 2007-10-04 Merck Sharp & Dohme Corp. Inhibitors of Akt activity
US8778963B2 (en) 2003-11-25 2014-07-15 3M Innovative Properties Company Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
AU2005283085B2 (en) * 2004-06-18 2012-06-21 3M Innovative Properties Company Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
WO2007056112A2 (en) * 2005-11-04 2007-05-18 Coley Pharmaceutical Group, Inc. Hydroxy and alkoxy substituted 1h-imidazoquinolines and methods
JP2010519309A (ja) * 2007-02-20 2010-06-03 ノバルティス アーゲー 脂質キナーゼおよびmTORのデュアル阻害剤としてのイミダゾキノリン
DK2155743T3 (da) * 2007-05-08 2012-11-05 Astrazeneca Ab Imidazoquinoliner med immunmodulerende egenskaber
SI2276486T1 (sl) 2008-03-24 2014-01-31 4Sc Discovery Gmbh Novi substituirani imidazokinolini
EP2419429B1 (en) 2009-04-16 2014-03-26 Centro Nacional de Investigaciones Oncológicas (CNIO) Imidazopyrazines as inhibitors of protein kinases
CN103012398B (zh) 2011-09-19 2015-10-14 上海恒瑞医药有限公司 咪唑并喹啉类衍生物及其可药用盐、其制备方法及其在医药上的应用
PT3679025T (pt) 2017-09-06 2022-06-01 BioNTech SE Imidazoquinolinas substituídas como agonistas de tlr7
WO2019048036A1 (en) * 2017-09-06 2019-03-14 Biontech Ag SUBSTITUTED IMIDAZOQUINOLINES

Also Published As

Publication number Publication date
EP3679038A1 (en) 2020-07-15
KR20200050963A (ko) 2020-05-12
ZA202001266B (en) 2021-08-25
US20220227756A1 (en) 2022-07-21
WO2019048036A1 (en) 2019-03-14
BR112020004504A2 (pt) 2020-09-15
RU2020112229A3 (ru) 2021-10-06
US20200317663A1 (en) 2020-10-08
CN111094287A (zh) 2020-05-01
JP2020532570A (ja) 2020-11-12
WO2019048350A1 (en) 2019-03-14
MX2020002367A (es) 2020-07-20
IL273002B1 (en) 2023-04-01
AU2018327414B2 (en) 2024-02-15
IL273002B2 (en) 2023-08-01
RU2768629C2 (ru) 2022-03-24
JP7241738B2 (ja) 2023-03-17
RU2020112229A (ru) 2021-10-06
US11267813B2 (en) 2022-03-08
EP3679038B1 (en) 2024-04-03
AU2018327414A1 (en) 2020-03-19
CA3074166A1 (en) 2019-03-14
ZA202101322B (en) 2022-09-28
IL273002A (en) 2020-04-30

Similar Documents

Publication Publication Date Title
DK3606954T3 (en) Anti-LAG3-antistoffer
DK3734167T3 (en) Airconditionsystem
DK3499914T3 (en) Høreapparatsystem
DK3700925T3 (en) Hidtil ukendt t-cellereceptor
ZA202101322B (en) Substituted imidazoquinolines
AU201714106S (en) Mandoline
DK3401557T3 (en) Træskrue
DK3485765T3 (en) Computerbord
DK3630041T3 (en) Stimulationsapparat
DK3718525T3 (en) Motoriseret asssistancesystem
DK3704866T3 (en) Datatransmissionssystem
GB201700825D0 (en) Poliovaccine
IL271290A (en) Dihydro-pyrrolo-pyridine derivatives
GB201702641D0 (en) Easpagnolette
DK3425793T3 (en) Tagsystem
DK3618761T3 (en) Intrakorporalt perfusionssystem
DK3351149T3 (en) Syltetøjsfontæne
AU201715236S (en) Striplight
AP00994S1 (en) Autorickshaw
GB201703085D0 (en) Beachbox 2017-F26
GB201703082D0 (en) Pantrap 2017-F26
GB201702896D0 (en) Alwitry pseudocapsule
GB201702755D0 (en) Bulgeomers
GB201702425D0 (en) Signitune
GB201702205D0 (en) Roadplate